Sionna Therapeutics, Inc. (SION)
4.895
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
4.895
0.00 (0.00%)
After-Hours: 20:00
Sionna Therapeutics Cash from Operations (Quarterly) : -22.22M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.22M |
| March 31, 2026 | -21.84M |
| December 31, 2025 | -16.63M |
| September 30, 2025 | -15.23M |
| June 30, 2025 | -18.15M |
| Date | Value |
|---|---|
| March 31, 2025 | -16.29M |
| December 31, 2024 | -11.78M |
| September 30, 2024 | -17.69M |
| June 30, 2024 | -10.14M |
| March 31, 2024 | -13.18M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.125B |
| Capricor Therapeutics, Inc. | -31.49M |
| ARS Pharmaceuticals, Inc. | -60.93M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Immunic, Inc. | -31.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 21.47M |
| Cash from Financing (Quarterly) | 0.749M |
| Free Cash Flow | -76.21M |
| Free Cash Flow Per Share (Quarterly) | -0.4921 |
| Free Cash Flow to Equity (Quarterly) | -21.91M |
| Free Cash Flow to Firm (Quarterly) | -22.22M |
| Free Cash Flow Yield | -34.71% |